Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Shares Outstanding (Diluted Average) (2023 - 2025)

Zhengye Biotechnology Holding has reported Shares Outstanding (Diluted Average) over the past 3 years, most recently at $6.7 million for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 5.01% to $6.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.7 million through Dec 2025, up 5.01% year-over-year, with the annual reading at $6.6 million for FY2025, 3.67% up from the prior year.
  • Shares Outstanding (Diluted Average) was $6.7 million for Q4 2025 at Zhengye Biotechnology Holding, down from $47.3 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $47.3 million in Q2 2025 and troughed at $6.3 million in Q4 2023.
  • The 3-year median for Shares Outstanding (Diluted Average) is $6.5 million (2025), against an average of $16.7 million.
  • Year-over-year, Shares Outstanding (Diluted Average) grew 0.24% in 2024 and then increased 5.01% in 2025.
  • A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $6.3 million in 2023, then grew by 0.24% to $6.4 million in 2024, then grew by 5.01% to $6.7 million in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Shares Outstanding (Diluted Average) are $6.7 million (Q4 2025), $47.3 million (Q2 2025), and $6.4 million (Q4 2024).